Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: HIKMA PHARMACEUTICALS USA INC.
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-01-07 to 2022-01-12
Current total value of award: $136.89
Description: 4555894585!DILTIAZEM 5 MG/ML INTRAVENOUS SOLUTION 1